RYAN THOMAS F JR 4
4 · REPLIGEN CORP · Filed Mar 2, 2022
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
RYAN THOMAS F JR
Director
Transactions
- Exercise/Conversion
Common Stock
2022-03-01$38.76/sh+1,000$38,760→ 3,457 total - Sale
Common Stock
2022-03-01$197.58/sh−1,000$197,580→ 1,457 total - Sale
Common Stock
2022-03-01$198.48/sh−1,000$198,480→ 2,457 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01+1,000→ 0 totalExercise: $38.76Exp: 2030-11-11→ Common Stock (1,000 underlying)
Footnotes (3)
- [F1]The total reported in Column 5 has been adjusted to correct an overstatement of total holdings by 9,880 shares, first reflected in a Form 4 filed on November 2, 2021.
- [F2]$198.48 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.19 to $198.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]This option is currently exercisable.